Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0I2MK
|
||||
Former ID |
DAP000481
|
||||
Drug Name |
Metoprolol
|
||||
Synonyms |
Beatrolol; BelocDuriles; Betaloc; BetalocAstra; Betalok; Dutoprol; LOPRESSIDONE; Lopresor; Lopresoretic; Lopressor; Meijoprolol; Metohexal; Metoprololum; Metroprolol; Preblok; Presolol; Seloken; Seroken; Spesicor; Spesikor; Toprol; AstraZeneca Brand of Metaoprolol Tartrate; AstraZeneca Brand of Seloken; Beloc Duriles; Betaloc Astra; Leiras Brand of Metoprolol Succinate or Metoprolol Tartrate; Metoprolol succinate; Novartis Brand of Metprolol Tartrate; Seloken AstraZeneca Brand; CGP 2175; CGP2175; H 93 26; H 9326; Beloc-Duriles; Betaloc (TN); Betaloc-Astra; CGP-2175; Corvitol (TN); Dl-Metoprolol; H 93-26; Lopressor (TN); Metoprololum [INN-Latin]; Metrol (TN); Minax (TN); Neobloc (TN); Selo-Zok; Selokeen (TN); TOPROL-XL; Tartrate, Metoprolol; Metoprolol (USAN/INN); Metoprolol [USAN:INN:BAN]; Toprol-XL (TN); (RS)-Metoprolol; 1-(Isopropylamino)-3-(4-(2-methoxyethyl)phenoxy)propan-2-ol; 1-(Isopropylamino)-3-(p-(2-methoxyethyl)phenoxy)-2-propanol; 1-(isopropylamino)-3-[4-(2-methoxyethyl)phenoxy]propan-2-ol; 1-[(1-methylethyl)amino]-3-({4-[2-(methyloxy)ethyl]phenyl}oxy)propan-2-ol; 1-[4-(2-methoxyethyl)phenoxy]-3-(propan-2-ylamino)propan-2-ol; 1-[4-(2-methoxyethyl)phenoxy]-3-propan-2-ylamino-propan-2-ol; 3-[4-(2-methoxyethyl)phenoxy]-1-(propan-2-ylamino)propan-2-ol
|
||||
Drug Type |
Small molecular drug
|
||||
Therapeutic Class |
Antihypertensive Agents
|
||||
Company |
AstraZeneca
|
||||
Structure |
Download2D MOL |
||||
Formula |
C15H25NO3
|
||||
InChI |
InChI=1S/C15H25NO3/c1-12(2)16-10-14(17)11-19-15-6-4-13(5-7-15)8-9-18-3/h4-7,12,14,16-17H,8-11H2,1-3H3
|
||||
InChIKey |
IUBSYMUCCVWXPE-UHFFFAOYSA-N
|
||||
CAS Number |
CAS 37350-58-6
|
||||
PubChem Compound ID | |||||
PubChem Substance ID |
9411, 4904669, 7849417, 7979976, 8152611, 10520685, 11533336, 14799183, 29223277, 46506211, 48416268, 49698871, 50023420, 50103878, 50103879, 50103880, 53790219, 56310948, 56313025, 56413044, 57322176, 78524559, 81040953, 85209393, 85789202, 92309031, 92717148, 93619457, 99234266, 103164420, 104179199, 104305635, 117664446, 124749948, 124886734, 125349182, 126443769, 126524234, 126628938, 126639359, 126654065, 126670412, 126687042, 126732563, 128220647, 131312492, 131472906, 132210550, 134337774, 135144539
|
||||
ChEBI ID |
ChEBI:6904
|
||||
SuperDrug ATC ID |
C07AB02
|
||||
SuperDrug CAS ID |
cas=037350586
|
||||
Target and Pathway | |||||
Target(s) | Beta-1 adrenergic receptor | Target Info | Antagonist | [535660], [536152], [538095] | |
PathWhiz Pathway | Muscle/Heart Contraction | ||||
References | |||||
Ref 525887 | Metoprolol: a review of its use in chronic heart failure. Drugs. 2000 Sep;60(3):647-78. | ||||
Ref 536116 | The effect of food on the relative bioavailability of rapidly dissolving immediate-release solid oral products containing highly soluble drugs. Mol Pharm. 2004 Sep-Oct;1(5):357-62. | ||||
Ref 540921 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 553). | ||||
Ref 535660 | Knockouts model the 100 best-selling drugs--will they model the next 100? Nat Rev Drug Discov. 2003 Jan;2(1):38-51. | ||||
Ref 536152 | Prediction and experimental validation of acute toxicity of beta-blockers in Ceriodaphnia dubia. Environ Toxicol Chem. 2005 Oct;24(10):2470-6. | ||||
Ref 538095 | Current therapeutic uses and potential of beta-adrenoceptor agonists and antagonists. Eur J Clin Pharmacol. 1998 Feb;53(6):389-404. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.